Skip to main content
. Author manuscript; available in PMC: 2010 Apr 19.
Published in final edited form as: Histopathology. 2009 Dec;55(6):696–704. doi: 10.1111/j.1365-2559.2009.03448.x

Table 3.

Nuclear and cytoplasmic distribution of RAD51 in prostate cancers with respect to Gleason score

Cancer grade BRCA1/2 cases
(combined)
Controls
Nuclear Cytoplasmic Nuclear Cytoplasmic
Gleason ≤ 7 0/6 (0) 3/6 (50%) 8/69 (12%) 15/69 (22%)
Gleason > 7 3/11 (27%) 6/11 (55%) 7/50 (14%) 21/50 (42%)
p-value 0.515 1.0 0.782 0.026